Neuroblastoma click to access explanations in the original CAP template

This is additional protocol for biopsy specimen.

OPTIONAL: Expert Consultation before completion of the reporting.

Other ancillary investigations included ALK mutation and amplification, ATRX mutation, etc.

INPC 1999



International Neuroblastoma Risk Group (INRG) Staging System (INRGSS)

INRG